Simultaneous determination of tegafur and gimeracil in human plasma by liquid chromatography/tandem mass spectrometry

Analytical Sciences

Volumn 25, Issue 10, 2009, Pages 1211-1215

  Gu, Y ^a,b   Lu, R ^b   Si, D ^a   Liu, C ^b  

^a TIANJIN UNIVERSITY   (China)

^b TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MASS SPECTROMETRY; METHANOL; PLASMA (HUMAN); POSITIVE IONS;

CHROMATOGRAPHIC SEPARATIONS; CONCENTRATION RANGES; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; MATRIX EFFECTS; POSITIVE ION MODE; SAMPLE PREPARATION; SELECTED REACTION MONITORING; SIMULTANEOUS DETERMINATIONS;

LIQUID CHROMATOGRAPHY;

EID: 72249096240     PISSN: 09106340     EISSN: 13482246     Source Type: Journal    
DOI: 10.2116/analsci.25.1211     Document Type: Article

References (20)

1. A. Beck, M.C. Etienne, S. Cheradame, J.L. Fischel, P. Formento, N. Renee, and G. Milano, Eur. J. Cancer, 1994, 30A, 1517.
2. T. Komatsu, H. Yamazaki, N. Shimada, S. Nagayama, Y. Kawaguchi, M. Nakajima, and T. Yokoi, Clin. Cancer Res., 2001, 7, 675.
3. Y.M. El Sayed and W. Sadee, Cancer Res., 1983, 43, 4039.
4. Y.M. El Sayed and W. Sadee, Biochem. Pharmacol, 1982, 31, 3006.
5. G.D. Heggie, J.P. Sommadossi, D.S. Cross, W.J. Huster, and R.B. Diasio, Cancer Res, 1987, 47, 2203.
6. K. Tatsumi, M. Fukushima, T. Shirasaka, and S. Fujii, Jpn. J. Cancer Res, 1987, 78, 748.
7. T. Shirasaka, Y. Shimamoto, H. Ohshimo, M. Yamaguchi, T. Kato, K. Yonekura, and M. Fukushima, Anti-Cancer Drugs, 1996, 7, 548.
8. T. Takechi, K. Nakano, J. Uchida, A. Mita, K. Toko, S. Takeda, N. Unemi, and T. Shirasaka, Cancer Chemother. Pharmacol., 1997, 39, 205.
9. K. Hirata, N. Horikoshi, M. Okazaki, R. Denno, K. Sasaki, Y. Nakano, H. Ishizuka, Y. Yamada, S. Uno, T. Taguchi, and T. Shirasaka, Y. Yamada, S. Uno, T. Taguchi, and T. Shirasaka, Clin Clin. Cancer Res, 1999, 5, 2000.
10. E. Matsushima, K. Yoshida, R. Kitamura, and K. Yoshida, Clin J. Chromatogr., B, 1997, 691, 95.
11. S.J. Cohen, C.G. Leichman, G. Yeslow, M. Beard, A. Proefrock, B. Roedig, B. Damle, S.P. Letrent, A.P. DeCillis, and N.J. Meropol, Yamada, S. Uno, T. Taguchi, and T. Shirasaka, Clin Clin. Cancer Res., 2002, 8, 2116.
12. M. Ikeda, H. Furukawa, H. Imamura, J. Shimizu, H. Ishida, S. Masutani, M. Tatsuta, T. Kawasaki, and T. Satomi, Cancer Chemother. Pharmacol, 2002, 50, 25.
13. G.J. Peters, P. Noordhuis, A.B. Van Kuilenburg, J.H. Schornagel, H. Gall, S.L. Turner, M.S. Swart, D. Voorn, A.H. Van Gennip, J. Wanders, U. Holwerda, K. Smid, G. Giaccone, P. Fumoleau, and C.J. Van Groeningen, Cancer Chemother. Pharmacol, 2003, 52, 1.
14. G.J. Peters, P. Noordhuis, C.J. Van Groeningen, G. Giaccone, U. Holwerda, D. Voorn, A. Schrijvers, J.H. Schornagel, J.H. Beijnen, P. Fumoleau, and J.H. Schellens, Clin. Cancer Res, 2004, 10, 4072.
15. Q.S. Chu, L.A. Hammond, G. Schwartz, L. Ochoa, S.Y. Rha, L. Denis, K. Molpus, B. Roedig, S.P. Letrent, B. Damle, A.P. DeCillis, and E.K. Rowinsky, Clin. Cancer Res, 2004, 10, 4913.
16. C. J. van Groeningen, G.J. Peters, J.H. Schornagel, H. Gall, P. Noordhuis, M.J. de Vries, S.L. Turner, M.S. Swart, H.M. Pinedo, A.R. Hanauske, and G. Giaccone, J. Clin. Oncol., 2000, 18, 2772.
17. V.R. Jarugula and F.D. Boudinot, J. Chromatogr., B, 1996, 677, 199.
18. D. Chu, J. Gu, W. Liu, F.J. Paul, and Q. Dong, J. Chromatogr., B, 2003, 795, 377.
19. L. Zufia, A. Aldaz, C. Castellanos, and J. Giraldez, Ther. Drug Monit, 2003, 25, 221.
20. G. Remaud, M. Boisdron-Celle, A. Morel, and A. Gamelin, J. Chromatogr., B, 2005, 824, 153.